The IL23R variant R381Q, with a reduced receptor activity on the autocrine and paracrine mechanism of IL23, was shown to be protective against IBD [24], and the absence of the IL23R results in a reduction in the proliferation of both Th1 and Th17 lymphocytes [25]. Here, IL37 is linked to inflammatory bowel disease.